Biochemistry

Date: May 16,1994, pp.16 R.A. Kahn, P. Randazzo, T. Serafini, O. Weiss, C. Rulka, J. Clark, M. Amherdt, P. Roller, L. Orci, J.E. Rothman, "The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport," Journal of Biological Chemistry, 267:13039-46, 1992. Richard A. Kahn (Laboratory of Biological Chemistry, National Cancer Institute, Beth

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Date: May 16,1994, pp.16

R.A. Kahn, P. Randazzo, T. Serafini, O. Weiss, C. Rulka, J. Clark, M. Amherdt, P. Roller, L. Orci, J.E. Rothman, "The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport," Journal of Biological Chemistry, 267:13039-46, 1992.

Richard A. Kahn (Laboratory of Biological Chemistry, National Cancer Institute, Bethesda, Md.): "Identified in 1980 as a factor required for the efficient ADP-ribosylation of the stimulatory, regulatory component of adenylate cyclase, Gs, ADP-ribosylation factor (ARF) remained a curiosity. By the late 1980s evidence accumulated that ARF proteins were involved in the regulation of protein traffic, though details were lacking. The lack of a neutralizing antibody and difficulty in obtaining subcellular fractions devoid of ARF made it difficult to define specific role(s) for ARF proteins using biochemical assays. "Our study led to the identification of a critical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies